Ann: ResApp Provides Updated Australian Paediatric Study Results, page-272

This.

Rolling announcements on adult trials commencement, fda, potential clients, release of those results, further fda, other left field agreements ala MGH 2 year agreement (unless exclusive), potential FIL and sideline holdings increasing or coming into play; this story has many chapters yet to be revealed over the next 6 months. Whilst focusing on escrow there will be other contributing factors that may just influence what happens with those shares IMO.